186 related articles for article (PubMed ID: 6454482)
1. Synergistic antileukemic activity of combinations of two nitrosoureas.
Wheeler GP; Schabel FM; Trader MW
Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
[TBL] [Abstract][Full Text] [Related]
2. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
3. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
4. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Pouillart R; Huong TH; Brugerie E; Lheritier J
Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
[No Abstract] [Full Text] [Related]
5. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
[No Abstract] [Full Text] [Related]
6. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
8. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Heal JM; Fox PA; Doukas D; Schein PS
Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy of L1210 mouse leukemia using a new water-soluble nitrosourea, 1-(2-chloroethyl)-3-(beta-d-glucopyranosyl)-1-nitrosourea, with various antimetabolites.
Nagura E; Hoshino A; Sugihara T; Machida S
Gan; 1980 Aug; 71(4):425-32. PubMed ID: 6448760
[No Abstract] [Full Text] [Related]
10. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
[TBL] [Abstract][Full Text] [Related]
11. Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.
Montgomery JA
Cancer Treat Rep; 1980; 64(8-9):987-91. PubMed ID: 7448833
[No Abstract] [Full Text] [Related]
12. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
13. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
Weinkam RJ; Dolan ME
J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
[TBL] [Abstract][Full Text] [Related]
14. Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair.
Kann HE; Schott MA; Petkas A
Cancer Res; 1980 Jan; 40(1):50-5. PubMed ID: 6444211
[No Abstract] [Full Text] [Related]
15. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
Johnston TP; Montgomery JA
Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
[No Abstract] [Full Text] [Related]
16. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
Macdonald JS; Hoth D; Schein PS
Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antileukemic effect of theophylline and 1,3-bis(2-chloroethyl)-1-nitrosourea.
DeWys WD; Bathina SH
Cancer Res; 1980 Jul; 40(7):2202-8. PubMed ID: 6248198
[TBL] [Abstract][Full Text] [Related]
19. Contributions of nitrosoureas to cancer treatment.
Mitchell EP; Schein PS
Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
[No Abstract] [Full Text] [Related]
20. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
Nagourney RA; Fox P; Schein PS
Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
